Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: A potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?

Amino Acids

Volumn 41, Issue 4, 2011, Pages 809-820

  Wolf, Susann ^a   Haase Kohn, Cathleen ^a   Lenk, Jens ^a   Hoppmann, Susan ^a,b   Bergmann, Ralf ^a   Steinbach, Joerg ^a   Pietzsch, Jens ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cells; Melanoma cells; Molecular imaging; Multiligand receptors; Protein radiolabeling; S100 proteins; Small animal positron emission tomography (PET)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALVASCULIN; FLUORINE 18; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; CELL SPECIFICITY; CLONING; CONJUGATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; EXPRESSION VECTOR; GLYCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MELANOMA CELL; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RAT; TISSUE SPECIFICITY;

ANIMALS; BENZOATES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FLUORINE RADIOISOTOPES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MELANOMA; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; S100 PROTEINS; SUCCINIMIDES;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS; RODENTIA;

EID: 83255173806     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0822-x     Document Type: Article

References (40)

1. Abe R, Shimizu T, Sugawara H, Watanabe H, Nakamura H, Choei H, Sasaki N, Yamagishi S, Takeuchi M, Shimizu H (2004) Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions. J Invest Dermatol 122:461-467
2. Adachi H, Tsujimoto M (2006) Endothelial scavenger receptors. Prog Lipid Res 45:379-404
3. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279:5059-5065
4. Berge G, Maelandsmo GM (2010) Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53. Amino Acids (in press)
5. Boyd JH, Kan B, Roberts H, Wang Y, Walley KR (2008) S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 102:1239-1246
6. Boye K, Maelandsmo GM (2010) S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176:528-535
7. Cunningham MF, Docherty NG, Burke JP, O'Connell PR (2010) S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration. Am J Physiol Gastrointest Liver Physiol 299:G457-G466
8. Dattilo BM, Fritz G, Leclerc E, Kooi CW, Heizmann CW, Chazin WJ (2007) The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46:6957-6970
9. Donato R (2007) RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med 7:711-724
10. Fernandez-Fernandez MR, Veprintsev DB, Fersht AR (2005) Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci USA 102:4735-4740
11. Garrett SC, Varney KM, Weber DJ, Bresnick AR (2006) S100A4, a mediator of metastasis. J Biol Chem 281:677-680
12. Gebhardt C et al (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205:275-285
13. Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M (2008) S100A8/ A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 83:1484-1492
14. Grigorian M et al (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276:22699-22708
15. Helfman DM, Kim EJ, Lukanidin E, Grigorian M (2005) The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92:1955-1958
16. Hofmann MA et al (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901
17. Hoppmann S, Steinbach J, Pietzsch J (2010) Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo. Int J Biochem Cell Biol 42:651-661
18. Hoppmann S, Haase C, Richter S, Pietzsch J (2008a) Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins-potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo. Protein Expr Purif 57:143-152
19. Hoppmann S, Haase C, Richter S, Strobel K, Steinbach J, Pietzsch J (2008b) Fluorine-18 radiolabeling of S100/calgranulins: potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo. In: Chen X (ed) Recent advances of bioconjugation chemistry in molecular imaging. Research Signpost, Trivandrum, pp 329-351
20. Hsieh HL, Schafer BW, Weigle B, Heizmann CW (2004) S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun 316:949-959
21. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275:40096-40105
22. (2+) signaling in neurons induced by the S100A4 protein. Mol Cell Biol 26:3625-3638
23. Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282: 31317-31331
24. Leclerc E, Heizmann CW, Vetter SW (2009a) RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells. Gen Physiol Biophys 28(Spec No Focus):F65- F75
25. Leclerc E, Fritz G, Vetter SW, Heizmann CW (2009b) Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793(6):993-1007
26. Li ZH, Dulyaninova NG, House RP, Almo SC, Bresnick AR (2010) S100A4 regulates macrophage chemotaxis. Mol Biol Cell 21:2598-2610
27. Logsdon CD, Fuentes MK, Huang EH, Arumugam T (2007) RAGE and RAGE ligands in cancer. Curr Mol Med 7:777-789
28. Miranda KJ, Loeser RF, Yammani RR (2010) Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13. J Biol Chem 285(41):31517-31524
29. Pietzsch J, Bergmann R, Wuest F, Pawelke B, Hultsch C, van den Hoff J (2005) Catabolism of native and oxidized low density lipoproteins: in vivo insights from small animal positron emission tomography studies. Amino Acids 29:389-404
30. Robinson MJ, Tessier P, Poulsom R, Hogg N (2002) The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277:3658-3665
31. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34(4):357-364
32. Schmidt AM, Yan SD, Wautier JL, Stern D (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84:489-497
33. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D, Alakhov V (2005) Metastasisassociated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 280:20833-20841
34. Sherbet GV (2009) Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 280:15-30
35. Stern D, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts: amultiligand receptormagnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615-1625
36. Tarabykina S, Griffiths TR, Tulchinsky E, Mellon JK, Bronstein IB, Kriajevska M (2007) Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets 7:217-228
37. Wolf R et al (2008) Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 181:1499-1506
38. Wolfe RR (1992) Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis. Wiley Liss, New York
39. Yammani RR, Carlson CS, Bresnick AR, Loeser RF (2006) Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 54:2901-2911
40. Zimmer DB, Wright Sadosky P, Weber DJ (2003) Molecular mechanisms of S100-target protein interactions. Microsc Res Tech 60:552-559